GI Partners to acquire majority interest in Clinical Ink
Existing Clinical Ink investor NovaQuest will continue to be a minority investor in the business.
Existing Clinical Ink investor NovaQuest will continue to be a minority investor in the business.
Copyright PEI Media
Not for publication, email or dissemination